不同基因表达平台对弥漫性大B细胞淋巴瘤细胞起源分类的高度一致性比较分析
该研究比较了四种基因表达平台(Illumina wG-DASL、Affymetrix PrimeView、Illumina TrueSeq RNA测序和HTG EdgeSeq DLBCL Cell of Origin Assay EU)对68例福尔马林固定石蜡包埋DLBCL样本进行细胞起源分类的结果,使用平台无关分类算法DAC和HTG平台原生分类器。结果显示分类方法和平台间高度一致,至少80%病例一致,高置信度分类一致率更高,表明基因表达谱分类稳健,临床应用中使用置信值很重要。
要点
- 四种平台对DLBCL细胞起源分类一致率至少80%。
- 高置信度分类的一致率远高于80%。
- 临床应用应结合置信值解读分类结果。
核心结论
- 不同基因表达平台对DLBCL细胞起源分类具有高度一致性,分类稳健。
- 临床应用中使用置信值辅助分类结果很重要。
研究设计与样本
- 比较研究,纳入68例福尔马林固定石蜡包埋DLBCL样本。
- 使用四种基因表达平台和两种分类算法(DAC和HTG原生分类器)。
主要发现
- 分类方法和平台间一致率至少80%。
- 高置信度分类的一致率远高于80%。
关键数值与推荐
- DLBCL细胞起源分为ABC、GCB和UNC/III型。
- HTG EdgeSeq DLBCL Cell of Origin Assay EU具有CE-IVD标记。
临床怎么用
- 基因表达谱可用于不同平台的DLBCL细胞起源分类。
- 解读分类结果时应同时考虑置信值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cell-of-origin subclassification of diffuse large B cell lymphoma (DLBCL) into activated B cell-like (ABC), germinal centre B cell-like (GCB) and unclassified (UNC) or type III by gene expression profiling is recommended in the latest update of the World Health Organization's classification of lymphoid neoplasms. There is, however, no accepted gold standard method or dataset for this classification. Here, we compare classification results using gene expression data for 68 formalin-fixed paraffin-embedded DLBCL samples measured on four different gene expression platforms (Illumina wG-DASLTM arrays, Affymetrix PrimeView arrays, Illumina TrueSeq RNA sequencing and the HTG EdgeSeq DLBCL Cell of Origin Assay EU using an established platform agnostic classification algorithm (DAC) and the classifier native to the HTG platform, which is CE marked for in vitro diagnostic use (CE-IVD). Classification methods and platforms show a high level of concordance, with agreement in at least 80% of cases and rising to much higher levels for classifications of high confidence. Our results demonstrate that cell-of-origin classification by gene expression profiling on different platforms is robust, and that the use of the confidence value alongside the classification result is important in clinical applications.
引用
- Ahmed S, Glover P, Taylor J, et al. Comparative analysis of gene expression platforms for cell-of-origin classification of diffuse large B-cell lymphoma shows high concordance. Br J Haematol. 2020. PMID: 33249557. doi:10.1111/bjh.17246
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。